Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome.
D000005:Abdomen; D002051:Burkitt Lymphoma / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D020031:Epstein-Barr Virus Infections / Q000150:complications; D005260:Female; D005767:Gastrointestinal Diseases / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D016040:Lung Transplantation / Q000009:adverse effects*; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology; D008232:Lymphoproliferative Disorders / Q000209:etiology* / Q000401:mortality / Q000628:therapy / Q000821:virology; D008297:Male; D008875:Middle Aged; D010388:Pelvis; D012189:Retrospective Studies; D013997:Time Factors
D007166:Immunosuppressive Agents